TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34548341

Group type: EXPERIMENTAL
Intervention: Modulable speed group (operators can choose ultrasound speed: 1420, 1480, or 1540 m/s)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional speed group (ultrasound speed fixed at 1540 m/s)
Number of subjects: 0
Study: 35809105

Group type: EXPERIMENTAL
Intervention: Medial congruent (MC) bearing
Number of subjects: 66

Group type: COMPARATOR
Intervention: Patient-reported outcome measures
Number of subjects: 66

Group type: COMPARATOR
Intervention: Clinical characteristics
Number of subjects: 66
Study: 33315415

Group type: EXPERIMENTAL
Intervention: Candidate-heterogeneous displays (equal numbers of high- and low-similarity candidates)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lures added a response time cost
Number of subjects: 0
Study: 33124563

Group type: EXPERIMENTAL
Intervention: Pharmacist's educational interview at baseline
Number of subjects: 89

Group type: COMPARATOR
Intervention: Control group (no educational interview until month 6)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 89
Study: 32766199

Group type: EXPERIMENTAL
Intervention: FCHV capacity building and mobile phone text messaging to expectant mothers
Number of subjects: 413

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 413
Study: 34288639

Group type: COMPARATOR
Intervention: Sugammadex
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Neostigmine/glycopyrrolate
Number of subjects: 181
Study: 32197933

Group type: EXPERIMENTAL
Intervention: Intravesical hyaluronic acid (HA) 40 mg (Hyacyst®) weekly for 4 weeks, then monthly for 3 months
Number of subjects: 20
Study: 35810525

Group type: EXPERIMENTAL
Intervention: Laughter yoga (8 sessions over 4 weeks, twice a week)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 101
Study: 34840600

Group type: EXPERIMENTAL
Intervention: Insulin therapy (10 units per 10 cm² of wound, injected in 1 mL 0.9% saline)
Number of subjects: 346

Group type: COMPARATOR
Intervention: Standard dressing with normal saline (Control)
Number of subjects: 346
Study: 33040106

Group type: EXPERIMENTAL
Intervention: Flipped classroom (Group A)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Traditional demonstration method (Group B)
Number of subjects: 40
Study: 34403911

Group type: COMPARATOR
Intervention: Docetaxel 75 mg/m2 intravenously on day 1 every 21 days
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Docetaxel 75 mg/m2 intravenously on day 1 plus erlotinib 150 mg/day orally on day 2-16 every 21 days
Number of subjects: 45
Study: 33460575

Group type: EXPERIMENTAL
Intervention: Unilateral strength training of the less affected wrist extensors
Number of subjects: 26

Group type: COMPARATOR
Intervention: Conventional physiotherapy
Number of subjects: 26
Study: 33315586

Group type: EXPERIMENTAL
Intervention: High volume injection without corticosteroids (50 mL saline and lidocaine)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo injection (2 mL saline and lidocaine)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: High volume injection without corticosteroids
Number of subjects: 80
Study: 34668986

Group type: EXPERIMENTAL
Intervention: Melatonin 10 mg daily during menstruation
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 33515784

Group type: EXPERIMENTAL
Intervention: 6-month mobile intervention based on social cognitive theory including behavioral lessons, adaptive goal-setting, tailored feedback, text messages, and Facebook prompts.
Number of subjects: 280

Group type: COMPARATOR
Intervention: Self-help control group receiving an activity tracker, mobile app, cellular-enabled scale, individual videochat session, and access to a Facebook group.
Number of subjects: 280
Study: 34613828

Group type: EXPERIMENTAL
Intervention: Parent mentor teaching We Can!
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Parent mentor teaching an intervention derived from positive deviance methods
Number of subjects: 188

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 188
Study: 34000843

Group type: EXPERIMENTAL
Intervention: Digital Working Alliance Inventory (DWAI)
Number of subjects: 604

Group type: COMPARATOR
Intervention: Waitlist condition
Number of subjects: 604
Study: 32682166

Group type: EXPERIMENTAL
Intervention: Acoustic change complex (ACC) assessment for difference limen for intensity (DLI)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard stimulus using a 1000 Hz stimulus
Number of subjects: 30
Study: 34676660

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT)
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Hypnotherapy (HT)
Number of subjects: 152

Group type: COMPARATOR
Intervention: Control (no specific control group mentioned)
Number of subjects: 152
Study: 32394656

Group type: EXPERIMENTAL
Intervention: Acupoint embedding therapy
Number of subjects: 210
Study: 34791296

Group type: EXPERIMENTAL
Intervention: Tenofovir disoproxil fumarate-containing arms
Number of subjects: 594

Group type: COMPARATOR
Intervention: Non-tenofovir disoproxil fumarate arms
Number of subjects: 594
Study: 34308356

Group type: EXPERIMENTAL
Intervention: Long-acting reversible contraception (LARC)
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Short-acting method
Number of subjects: 208

Group type: COMPARATOR
Intervention: Age
Number of subjects: 208

Group type: COMPARATOR
Intervention: Education
Number of subjects: 208

Group type: COMPARATOR
Intervention: Sexual activity
Number of subjects: 208
Study: 35855818

Group type: EXPERIMENTAL
Intervention: Augmented reality-based training (ART)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Mirror visual feedback training (MVFT)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Therapist-based training (TBT)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 48
Study: 34238363

Group type: EXPERIMENTAL
Intervention: Blended learning education program on lifestyle changes for management of high blood pressure
Number of subjects: 300

Group type: COMPARATOR
Intervention: Information booklets and general advice
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Blended learning education program
Number of subjects: 300
Study: 33290446

Group type: EXPERIMENTAL
Intervention: Systemic prednisone and nasal irrigation with betamethasone, ambroxol and rinazine for 15 days
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group (untreated)
Number of subjects: 18
Study: 35685657

Group type: EXPERIMENTAL
Intervention: Pulsed Radiofrequency (RF) therapy
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A (BoNT-A) injection
Number of subjects: 100
Study: 34401369

Group type: EXPERIMENTAL
Intervention: epos (emotion-based psycho-oncological online self-help)
Number of subjects: 325

Group type: COMPARATOR
Intervention: Informational website (control group)
Number of subjects: 325
Study: 35130966

Group type: EXPERIMENTAL
Intervention: Action observation therapy (AOT) group observing videos of eccentric exercises prior to performing the exercises.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group observing videos of landscapes prior to performing the eccentric exercises.
Number of subjects: 0
Study: 35752215

Group type: EXPERIMENTAL
Intervention: Age-appropriate intervention consisting of problem-solving therapy, behavioral activation, parenting skills training, and parenting support from a self-identified adult
Number of subjects: 242

Group type: COMPARATOR
Intervention: Care as usual (Control)
Number of subjects: 242
Study: 33305660

Group type: EXPERIMENTAL
Intervention: Ticagrelor monotherapy (TIC)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Ticagrelor and Aspirin (TIC+ASP)
Number of subjects: 110
Study: 34627141

Group type: COMPARATOR
Intervention: artemether-lumefantrine (AL)
Number of subjects: 870

Group type: EXPERIMENTAL
Intervention: amodiaquine-artesunate (ASAQ)
Number of subjects: 870

Group type: EXPERIMENTAL
Intervention: dihydroartemisinin-piperaquine (DHAPQ)
Number of subjects: 870

Group type: EXPERIMENTAL
Intervention: concomitant medication
Number of subjects: 870

Group type: EXPERIMENTAL
Intervention: total bilirubin
Number of subjects: 870

Group type: EXPERIMENTAL
Intervention: alanine aminotransferase
Number of subjects: 870
Study: 32106225

Group type: EXPERIMENTAL
Intervention: Housing First treatment (rent supplements and mental health support services)
Number of subjects: 414

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 414
Study: 35165925

Group type: EXPERIMENTAL
Intervention: Isavuconazole
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fluconazole
Number of subjects: 0
Study: 33252482

Group type: EXPERIMENTAL
Intervention: Precision respondent-driven sampling (pRDS) with 5 recruitment coupons for high probability individuals
Number of subjects: 1631

Group type: COMPARATOR
Intervention: Standard respondent-driven sampling (RDS) with 2 recruitment coupons
Number of subjects: 1631

Group type: EXPERIMENTAL
Intervention: Precision respondent-driven sampling (pRDS)
Number of subjects: 1631

Group type: COMPARATOR
Intervention: Standard respondent-driven sampling (RDS)
Number of subjects: 1631
Study: 32199021

Group type: EXPERIMENTAL
Intervention: Balneotherapy (BT) plus Physical Therapy (PT)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Physical Therapy (PT) only
Number of subjects: 60
Study: 36075595

Group type: EXPERIMENTAL
Intervention: Chicken‐claw needling at Xiaguan (ST 7) combined with intradermal needling, once a day for 6 days, total of 2 courses.
Number of subjects: 60

Group type: COMPARATOR
Intervention: Oral carbamazepine tablets for 13 days.
Number of subjects: 60
Study: 33609476

Group type: EXPERIMENTAL
Intervention: Tilavonemab 2000 mg
Number of subjects: 378

Group type: EXPERIMENTAL
Intervention: Tilavonemab 4000 mg
Number of subjects: 378

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 378
Study: 36026789

Group type: EXPERIMENTAL
Intervention: TensioBot (chatbot)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Control group (paper annotations)
Number of subjects: 112
Study: 34274708

Group type: EXPERIMENTAL
Intervention: Couple-based physical activity promotion intervention over six months
Number of subjects: 264

Group type: EXPERIMENTAL
Intervention: Couple-based physical activity promotion intervention
Number of subjects: 264
Study: 33152522

Group type: EXPERIMENTAL
Intervention: PREDID trial (active discopathy)
Number of subjects: 256

Group type: COMPARATOR
Intervention: Independent cohort (no active discopathy)
Number of subjects: 256
Study: 36297495

Group type: EXPERIMENTAL
Intervention: ADV6209 (0.25 mg kg−1)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Conventional midazolam (0.25 mg kg−1)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: ADV6209
Number of subjects: 80

Group type: COMPARATOR
Intervention: Conventional midazolam
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: ADV6209 and Conventional midazolam
Number of subjects: 80
Study: 33044768

Group type: EXPERIMENTAL
Intervention: Grape seed extract (GSE) 300 mg/day
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 34486319

Group type: EXPERIMENTAL
Intervention: Wheat bran (40 g per day for 30 days)
Number of subjects: 160
Study: 36344969

Group type: EXPERIMENTAL
Intervention: Photoselective sharp enucleation of the prostate (PSEP)
Number of subjects: 154

Group type: COMPARATOR
Intervention: Photoselective vaporization of the prostate (PVP)
Number of subjects: 154
Study: 32366796

Group type: EXPERIMENTAL
Intervention: PBMT at 260 J
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: PBMT at 130 J
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo (0 J)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: PBMT (all doses)
Number of subjects: 27
Study: 35092071

Group type: EXPERIMENTAL
Intervention: CenteringPregnancy (CP)
Number of subjects: 2562
Study: 34160776

Group type: COMPARATOR
Intervention: Placebo administration
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Non-placebo condition
Number of subjects: 23
Study: 33219142

Group type: EXPERIMENTAL
Intervention: rozanolixizumab 7 mg/kg
Number of subjects: 43

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 43
Study: 32040542

Group type: EXPERIMENTAL
Intervention: Referral from a lower health facility
Number of subjects: 540

Group type: EXPERIMENTAL
Intervention: Prime parity
Number of subjects: 540

Group type: EXPERIMENTAL
Intervention: Use of herbal medicines in active labour
Number of subjects: 540

Group type: EXPERIMENTAL
Intervention: Being married
Number of subjects: 540

Group type: EXPERIMENTAL
Intervention: Having a delivery plan
Number of subjects: 540

Group type: EXPERIMENTAL
Intervention: Having an educated partner
Number of subjects: 540

Group type: EXPERIMENTAL
Intervention: Four or more ANC visits
Number of subjects: 540
Study: 33847190

Group type: EXPERIMENTAL
Intervention: RCTs
Number of subjects: 40

Group type: COMPARATOR
Intervention: RLSs
Number of subjects: 40
Study: 36440648

Group type: EXPERIMENTAL
Intervention: Nursing care based on the Levine's Conservation Model
Number of subjects: 65
Study: 33427009

Group type: EXPERIMENTAL
Intervention: Warning labels
Number of subjects: 722

Group type: EXPERIMENTAL
Intervention: Pro-drinking comments
Number of subjects: 722

Group type: COMPARATOR
Intervention: No comments, pro-drinking comments, anti-drinking comments, warning labels, or industry responsibility messages
Number of subjects: 722
Study: 32505383

Group type: EXPERIMENTAL
Intervention: 75 mg linzagolix
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 100 mg linzagolix
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 200 mg linzagolix
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: linzagolix (doses ≥ 75 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: linzagolix
Number of subjects: 0
Study: 87266332

Group type: EXPERIMENTAL
Intervention: Cefuroxime (two-dose peroperative regimen)
Number of subjects: 418

Group type: COMPARATOR
Intervention: Ampicillin and metronidazole (combined peroperative and postoperative for 4 days)
Number of subjects: 418
Study: 35427191

Group type: EXPERIMENTAL
Intervention: Immediate Group (ELEVATE intervention)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Delay Group (3-month waitlist control)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Parent-trained children
Number of subjects: 34
Study: 34304981

Group type: EXPERIMENTAL
Intervention: STAND Clinic (intervention)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Usual Care (control)
Number of subjects: 48
Study: 34106449

Group type: EXPERIMENTAL
Intervention: Greater socioeconomic status
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Chinese subgroup
Number of subjects: 400
Study: 33068345

Group type: EXPERIMENTAL
Intervention: Scraping on head and face combined with stepping technique of tuina along lower limbs, applied once every 3 days for a total of 10 times.
Number of subjects: 100

Group type: COMPARATOR
Intervention: Oryzanol tablets and compound vitamin B tablets, 2 tablets each, 3 times daily for 30 days.
Number of subjects: 100
Study: 32188793

Group type: EXPERIMENTAL
Intervention: PTFV1
Number of subjects: 2556
Study: 34964230

Group type: EXPERIMENTAL
Intervention: Microneedling + Trichloroacetic Acid (TCA)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Microneedling + 5-Fluorouracil (5-FU)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Microneedling + Pimecrolimus
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 75
Study: 34476446

Group type: EXPERIMENTAL
Intervention: 3D printing technology under three-dimensional reconstruction
Number of subjects: 84

Group type: COMPARATOR
Intervention: Routine operation
Number of subjects: 84
Study: 35863457

Group type: EXPERIMENTAL
Intervention: Oteseconazole (600 mg on day 1 and 450 mg on day 2)
Number of subjects: 219

Group type: COMPARATOR
Intervention: Fluconazole (3 sequential 150 mg doses every 72 hours)
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: Oteseconazole (150 mg weekly for 11 weeks)
Number of subjects: 219

Group type: COMPARATOR
Intervention: Placebo (150 mg weekly for 11 weeks)
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: Oteseconazole (induction and maintenance phases)
Number of subjects: 219

Group type: COMPARATOR
Intervention: Fluconazole (induction phase) and Placebo (maintenance phase)
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: Oteseconazole/oteseconazole group
Number of subjects: 219

Group type: COMPARATOR
Intervention: Fluconazole/placebo group
Number of subjects: 219
Study: 33876875

Group type: EXPERIMENTAL
Intervention: L-citrulline (3 g/day)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study: 36148578

Group type: EXPERIMENTAL
Intervention: 4-hour semifluid and 2-hour water fasting protocol ('4+2' protocol)
Number of subjects: 214

Group type: COMPARATOR
Intervention: Conventional fasting
Number of subjects: 214
Study: 33632285

Group type: EXPERIMENTAL
Intervention: Mannose supplementation
Number of subjects: 0

Group type: COMPARATOR
Intervention: No mannose supplementation
Number of subjects: 0
Study: 32109881

Group type: EXPERIMENTAL
Intervention: Low Physical Activity (LPA)
Number of subjects: 10000
Study: 35363054

Group type: EXPERIMENTAL
Intervention: Medtronic advanced hybrid closed-loop (AHCL) system
Number of subjects: 112

Group type: COMPARATOR
Intervention: Medtronic MiniMed™ 670G hybrid closed-loop system (670G)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Both treatment arms (AHCL and 670G)
Number of subjects: 112
Study: 34103898

Group type: EXPERIMENTAL
Intervention: DA-8031 20 mg
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: DA-8031 30 mg
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: DA-8031 40 mg
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: CYP2D6 intermediate metabolizer
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 35263755

Group type: EXPERIMENTAL
Intervention: Once-weekly lonapegsomatropin 0.24 mg human growth hormone/kg/week
Number of subjects: 146

Group type: COMPARATOR
Intervention: Daily somatropin therapy
Number of subjects: 146
Study: 33125679

Group type: EXPERIMENTAL
Intervention: Eichhornia crassipes
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Pistia stratiotes
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Salvinia molesta
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Eichhornia crassipes and Pistia stratiotes
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Eichhornia crassipes and Salvinia molesta
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Pistia stratiotes and Salvinia molesta
Number of subjects: 7

Group type: COMPARATOR
Intervention: Without plant, treated only with sedimentation
Number of subjects: 7
Study: 35813258

Group type: EXPERIMENTAL
Intervention: Mount Sinai Prebiopsy Risk Calculator (MSP-RC)
Number of subjects: 1902

Group type: COMPARATOR
Intervention: Advanced Neural Networking (ANN)
Number of subjects: 1902

Group type: COMPARATOR
Intervention: European Randomized Study of Screening for Prostate Cancer Risk Calculator (ERSPC RC)
Number of subjects: 1902

Group type: COMPARATOR
Intervention: Prostate MRI Outcome Database (PROMOD)
Number of subjects: 1902
Study: 33050945

Group type: EXPERIMENTAL
Intervention: Famotidine 160 mg four times a day for up to 14 days
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo in the same dosage as Famotidine
Number of subjects: 20
Study: 35956324

Group type: EXPERIMENTAL
Intervention: Oat bran (30 g/d, containing DF 8.9 g)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Regular DASH dietary care
Number of subjects: 70
Study: 33675624

Group type: EXPERIMENTAL
Intervention: In situ placement of the ulnar nerve in the cubital tunnel
Number of subjects: 58

Group type: COMPARATOR
Intervention: Anterior transposition of the ulnar nerve
Number of subjects: 58
Study: 32020530

Group type: COMPARATOR
Intervention: Pazopanib 800 mg once daily (QD)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Pazopanib 400 mg twice daily
Number of subjects: 9
Study: 35835336

Group type: EXPERIMENTAL
Intervention: Tube shunt (350‐mm2 Baerveldt glaucoma implant)
Number of subjects: 242

Group type: COMPARATOR
Intervention: Trabeculectomy with mitomycin C (MMC, 0.4 mg/ml for 2 minutes)
Number of subjects: 242
Study: 33811803

Group type: EXPERIMENTAL
Intervention: Self-administration of medication programme
Number of subjects: 60

Group type: COMPARATOR
Intervention: Routine medication administration (Control)
Number of subjects: 60
Study: 35989964

Group type: EXPERIMENTAL
Intervention: Bottle-positive expiratory pressure (PEP)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Breathing exercises (control group)
Number of subjects: 24
Study: 34697401

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Duloxetine
Number of subjects: 196

Group type: COMPARATOR
Intervention: Baseline indoxyl sulfate abundance
Number of subjects: 196

Group type: COMPARATOR
Intervention: Baseline indole abundances
Number of subjects: 196

Group type: COMPARATOR
Intervention: Changes in symptoms
Number of subjects: 196
Study: 33319490

Group type: EXPERIMENTAL
Intervention: TEACHES-LEM
Number of subjects: 117

Group type: COMPARATOR
Intervention: F2FT
Number of subjects: 117
Study: 33252929

Group type: EXPERIMENTAL
Intervention: rBWL + Peer
Number of subjects: 278

Group type: EXPERIMENTAL
Intervention: rBWL + Mentor
Number of subjects: 278

Group type: COMPARATOR
Intervention: rBWL
Number of subjects: 278
Study: 36400420

Group type: EXPERIMENTAL
Intervention: Intrapartum ultrasound (IPUS) for labor progress assessment, avoiding digital exams as much as possible.
Number of subjects: 182

Group type: COMPARATOR
Intervention: Control group with regular protocol for labor progress assessment.
Number of subjects: 182
Study: 33930381

Group type: EXPERIMENTAL
Intervention: Short-form Reproductive Coercion Scale
Number of subjects: 628
Study: 32020567

Group type: EXPERIMENTAL
Intervention: Surgery (subtotal or gross-total resection)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Chemotherapy (imatinib, bevacizumab)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: SBRT (Stereotactic Body Radiotherapy)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Aggressive multi-modality treatment options
Number of subjects: 16